Detalhe da pesquisa
1.
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa.
Mol Ther
; 30(8): 2680-2692, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35490295
2.
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer.
Int J Mol Sci
; 23(1)2022 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008999
3.
Human TCR transgenic Bet v 1-specific Th1 cells suppress the effector function of Bet v 1-specific Th2 cells.
J Immunol
; 187(8): 4077-87, 2011 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21908735
4.
Bet v 1-specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1-specific T-cell effector function in an activation-dependent manner.
J Allergy Clin Immunol
; 127(1): 238-45, 245.e1-3, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21211658
5.
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34675067
6.
Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice.
EBioMedicine
; 31: 66-78, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29678672
7.
Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
J Invest Dermatol
; 138(5): 1197-1200, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203361